Scholar Rock Holding Corporation (SRRK) vs TransMedics Group, Inc. (TMDX)
A side-by-side comparison of Scholar Rock Holding Corporation and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 3, 2026. Differences are shown without an overall score or investment verdict.
SRRK
Scholar Rock Holding Corporation
$55.94HealthcareDelayed quote: Sep 3, 2026, 4:00 PM EDT
TMDX
TransMedics Group, Inc.
$86.98HealthcareDelayed quote: Sep 3, 2026, 4:00 PM EDT
Total return — SRRK vs TMDX
growth of $100 · dividends reinvested · last 7ySRRK +167.3% (+15.1%/yr)TMDX +277.0% (+20.9%/yr)TMDX compounded faster over this window
SRRK TMDX
SRRK vs TMDX: by the numbers
- •SRRK is the larger company ($6.70B vs $3.01B market cap).
- •TMDX is profitable (22.69% net margin) while SRRK runs a net loss (0.00%).
- •SRRK grew revenue faster over the past five years (110.77% vs 86.12% CAGR).
Metrics side by side
Valuation
| Metric | SRRK | TMDX |
|---|---|---|
| P/E ratio | N/A | 21.84 |
| Forward P/E | N/A | 56.34 |
| P/S ratio | N/A | 5.13 |
| P/B ratio | 28.87 | 6.62 |
| EV / EBITDA | N/A | 32.42 |
| FCF yield | N/A | 2.30% |
Profitability
| Metric | SRRK | TMDX |
|---|---|---|
| Gross margin | 0.00% | 58.69% |
| Operating margin | 0.00% | 12.21% |
| Net margin | 0.00% | 22.69% |
| ROE | -161.00% | 29.28% |
| ROIC | -90.04% | 5.87% |
Growth (annualized)
| Metric | SRRK | TMDX |
|---|---|---|
| Revenue CAGR (5Y) | 110.77% | 86.12% |
| Total return CAGR (5Y) | 7.65% | 20.20% |
Frequently asked
- Which has grown faster, SRRK or TMDX?
- Over the past five years, SRRK grew revenue faster — SRRK at a 110.77% CAGR versus TMDX at 86.12%.
- Is SRRK or TMDX more profitable?
- TMDX runs the higher net margin — SRRK at 0.00% versus TMDX at 22.69%.
- How have SRRK and TMDX total returns compared?
- Over the past 5 years, SRRK delivered 7.65% and TMDX delivered 20.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
TransMedics P/E ratioScholar Rock ROETransMedics ROEScholar Rock operating marginTransMedics operating marginScholar Rock revenue growthTransMedics revenue growthScholar Rock free cash flowTransMedics free cash flow
Scholar Rock & TransMedics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 3, 2026.